Brief: Viva Biotech Holdings Posts FY Profit RMB 265.9 Mln
30/03/2020 16:14
March 30 (Reuters) - VIVA Biotech Holdings 1873.HK :
* FY PROFIT RMB265.9 MILLION VERSUS RMB90.6 MILLION
* FY REVENUE RMB323.1 MILLION VERSUS RMB210MLN
* AS OF MARCH 30, COVID-19 OUTBREAK HAS NOT RESULTED IN ANY
SIGNIFICANT IMPACT TO GROUP'S OPERATION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS6vT2nP
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical